SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001062993-19-000013
Filing Date
2019-01-03
Accepted
2019-01-03 12:38:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga_enzn.htm SC 13G/A 25035
  Complete submission text file 0001062993-19-000013.txt   26853
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-35587 | Film No.: 19504271
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2945 S CENTER GREEN CT G215 BOULDER CO 80301
Business Address 2945 S CENTER GREEN CT G215 BOULDER CO 80301 404-451-7432
HARPER ASSET MANAGEMENT LLC (Filed by) CIK: 0001586910 (see all company filings)

IRS No.: 582648461 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G/A